Biontech, an immunotherapy spinout of Johannes Gutenberg University Mainz, has received an undisclosed amount of equity funding as part of a collaboration deal that could reach $425m.
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Ascentage, based on research at University of Michigan, has increased its total funding to more than $240m after closing a $150m series C round.
The Stanford-StartX Fund-backed electric scooter and bike rental service has raised $335m in a GV-led round that also included Uber.
Duke Management Company and Osage University Partners have invested in the genome editing technology spinout from Duke University.